The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...

The Panhandle Orphan Care Network (POCN) is partnering with the Greater Amarillo Foster Parent Association (GAFPA) to help ...

The Division of Oil and Gas Resources Management has been using drones in Allen, Auglaize, Hancock, Mercer, and Wood counties ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Each character in The Stone of Madness, including a mute man, an orphan and a woman proficient in witchcraft, has strengths ...

In 1888, struck by the number of orphans she was continuing to find around Atlanta, she founded the Carrie Steele Orphans Home.

Ariceum Therapeutics GmbH’s radiopharmaceutical 225Ac-SSO110 ([225Ac]satoreotide tetraxetran) has been awarded orphan drug designation by the FDA for the treatment of small-cell lung cancer (SCLC).

Arbor Biotechnologies Inc.’s ABO-101 has been awarded orphan drug and rare pediatric disease designations by the FDA for the treatment of primary hyperoxaluria type 1 (PH1).

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...

With its rich culture, breathtaking sights and intriguing landmarks, it’s not surprising that France is on the travel bucket ...

As we grieve our losses, I’m comforted and humbled to know that the persecuted church is interceding on our behalf.